FDA Grants Accelerated Approval to Ibrance In HER2-Negative Metastatic Breast Cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

YOU MAY BE INTERESTED IN

The California Institute for Regenerative Medicine, a state agency tasked with awarding billions of dollars of scientific funding for stem cell and gene therapy, has rescinded a controversial policy that was disrupting the flow of funding to cancer research.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login